Profile | GDS4284 / 218490_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4258.23 | 92 |
GSM687648 | Patient 402 control | 3608.95 | 90 |
GSM687653 | Patient 403 control | 4029.74 | 91 |
GSM687658 | Patient 404 control | 2270.07 | 85 |
GSM687663 | Patient 411 control | 2426.25 | 86 |
GSM687668 | Patient 422 control | 3106.24 | 89 |
GSM687673 | Patient 424 control | 2255.74 | 85 |
GSM687678 | Patient 425 control | 1954.67 | 83 |
GSM687683 | Patient 427 control | 2625.14 | 87 |
GSM687688 | Patient 428 control | 1964.48 | 84 |
GSM687695 | Patient 441 control | 394.971 | 56 |
GSM687699 | Patient 443 control | 2722.56 | 88 |
GSM687704 | Patient 444 control | 2881.06 | 88 |
GSM687707 | Patient 448 control | 2738.94 | 88 |
GSM687712 | Patient 449 control | 3928.91 | 91 |
GSM687719 | Patient 450 control | 2890.97 | 89 |
GSM687724 | Patient 451 control | 3480.6 | 90 |
GSM687728 | Patient 452 control | 2033.39 | 84 |
GSM687646 | Patient 401 treated 24h | 3483.27 | 90 |
GSM687649 | Patient 402 treated 24h | 5068.94 | 93 |
GSM687665 | Patient 411 treated 24h | 2386.12 | 86 |
GSM687651 | Patient 402 treated 4 weeks | 2726.29 | 88 |
GSM687667 | Patient 411 treated 4 weeks | 3837.79 | 91 |
GSM687670 | Patient 422 treated 24h | 2703.31 | 88 |
GSM687671 | Patient 422 treated 4 weeks | 2604.96 | 87 |
GSM687654 | Patient 403 treated 24h | 3565.88 | 90 |
GSM687675 | Patient 424 treated 24h | 2393.44 | 86 |
GSM687685 | Patient 427 treated 24h | 2288.38 | 86 |
GSM687656 | Patient 403 treated 4 weeks | 3449.42 | 90 |
GSM687677 | Patient 424 treated 4 weeks | 1988.23 | 84 |
GSM687687 | Patient 427 treated 4 weeks | 3935.42 | 91 |
GSM687692 | Patient 428 treated 4h | 3988.68 | 91 |
GSM687716 | Patient 449 treated 4h | 3779.59 | 91 |
GSM687722 | Patient 450 treated 4h | 2144.94 | 85 |
GSM687680 | Patient 425 treated 24h | 2013.05 | 84 |
GSM687690 | Patient 428 treated 24h | 4674.62 | 93 |
GSM687700 | Patient 443 treated 24h | 1161.82 | 76 |
GSM687705 | Patient 444 treated 24h | 2016.89 | 84 |
GSM687714 | Patient 449 treated 24h | 3470.23 | 90 |
GSM687721 | Patient 450 treated 24h | 1544.83 | 81 |
GSM687682 | Patient 425 treated 4 weeks | 1640.16 | 81 |
GSM687694 | Patient 428 treated 4 weeks | 2848.39 | 88 |
GSM687702 | Patient 443 treated 4 weeks | 2911.84 | 88 |
GSM687718 | Patient 449 treated 4 weeks | 3399.27 | 90 |
GSM687723 | Patient 450 treated 4 weeks | 2997.45 | 89 |
GSM687661 | Patient 404 treated 4h | 3189.83 | 89 |
GSM687710 | Patient 448 treated 4h | 2300.88 | 86 |
GSM687726 | Patient 451 treated 4h | 2700.87 | 88 |
GSM687730 | Patient 452 treated 4h | 1089.08 | 75 |
GSM687660 | Patient 404 treated 24h | 1510.64 | 82 |
GSM687697 | Patient 441 treated 24h | 608.861 | 66 |
GSM687709 | Patient 448 treated 24h | 2800.86 | 88 |
GSM687725 | Patient 451 treated 24h | 3220.55 | 90 |
GSM687729 | Patient 452 treated 24h | 965.755 | 75 |
GSM687727 | Patient 451 treated 4 weeks | 2264.42 | 86 |
GSM687731 | Patient 452 treated 4 weeks | 1104.32 | 75 |